MSF Welcomes New Fixed-Dose Combination Against Malaria

Doctors Without Borders/Medecins Sans Frontieres (MSF) welcomes the launch in Brazil of a new drug against P. Falciparum, the most dangerous type of malaria. Developed by DNDi (Drugs for Neglected Diseases Initiative) in partnership with Farmanguinhos/Fiocruz, ASMQ is the first drug against malaria that combines artesunate (AS) and mefloquine (MQ) in one fixed dose.

More: continued here

Filed under: Tropical on May 15th, 2008